여시니아 진단 시장 규모, 점유율, 성장 분석 : 제품별, 진단 검사별, 기술별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Yersinia Diagnostics Market size was valued at USD 3.62 Billion in 2024 and is poised to grow from USD 3.77 Billion in 2025 to USD 5.24 Billion by 2033, growing at a CAGR of 4.2% during the forecast period (2026-2033).

The global Yersinia diagnostics market is primarily fueled by the rising incidence of Yersinia infections, advancements in diagnostic technology, and heightened awareness surrounding early detection and treatment. Technological innovations, particularly in molecular diagnostics, are key growth catalysts, alongside increased public health education on food-borne diseases. The escalating number of yersiniosis cases also contributes to market expansion. However, market growth faces potential restraints from heightened competition among producers, limited government healthcare funding, and bulk purchasing by organizations. The market spans across multiple regions, with North America, Europe, and Asia Pacific as significant contributors, featuring both established and emerging companies delivering diverse diagnostic products and services. Government initiatives and investments in healthcare infrastructure are expected to bolster future growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Yersinia Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Yersinia Diagnostics Market Segments Analysis

Global Yersinia Diagnostics Market is segmented by Product, Diagnostic Test, Technology, End User and region. Based on Product, the market is segmented into Instruments and Kits and Reagents. Based on Diagnostic Test, the market is segmented into Stool Culture, Imaging Tests, Serological Tests, Colonoscopy, ELISA, Radioimmunoassay, Tube Agglutination, CT Scan, Ultrasonography, Colonoscopy and Others. Based on Technology, the market is segmented into Immunoassay, DNA Probes, Polymerase Chain Reaction (PCR), Flow Cytometry, Chromatography and Others. Based on End User, the market is segmented into Hospitals, Public Health Laboratories, Commercial Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Yersinia Diagnostics Market

One of the key market drivers for the global Yersinia diagnostics market is the increasing prevalence of Yersinia infections, particularly Yersinia pestis, which is responsible for plague, and Yersinia enterocolitica, a leading cause of gastroenteritis. The rise in infection rates, often linked to environmental factors, travel, and urbanization, has heightened the need for accurate and rapid diagnostic tests. Additionally, the growing awareness of zoonotic diseases and the importance of early detection in controlling outbreaks are propelling investments in research and development of sophisticated diagnostic tools, ultimately driving market growth and enhancing public health response mechanisms.

Restraints in the Global Yersinia Diagnostics Market

One significant market restraint for the global Yersinia diagnostics market is the limited awareness and understanding of Yersinia infections among healthcare professionals and the general public. This knowledge gap can lead to misdiagnosis or delayed diagnosis, subsequently hindering the demand for accurate diagnostic tools. Additionally, the relatively low prevalence of Yersinia infections in many regions may result in insufficient funding and research initiatives aimed at developing advanced diagnostic solutions, further impeding market growth. As a result, the lack of visibility and urgency surrounding Yersinia-related health issues poses a challenge for manufacturers and stakeholders in this specialized market segment.

Market Trends of the Global Yersinia Diagnostics Market

The Global Yersinia Diagnostics market is witnessing a significant shift towards molecular diagnostics, characterized by the growing adoption of innovative techniques such as polymerase chain reaction (PCR) assays and nucleic acid amplification tests (NAATs) for effective Yersinia detection. These advanced molecular methods are favored for their superior sensitivity and specificity compared to traditional culture-based techniques, alongside their ability to deliver rapid turnaround times. The capability to directly identify Yersinia DNA from clinical samples facilitates prompt and accurate diagnoses, prompting healthcare providers and laboratories to invest more heavily in molecular diagnostic platforms and assays, thereby catalyzing robust market growth in this segment.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement

Global Yersinia Diagnostics Market Size by Product & CAGR (2026-2033)

• Market Overview
• Instruments
• Kits and Reagents

Global Yersinia Diagnostics Market Size by Diagnostic Test & CAGR (2026-2033)

• Market Overview
• Stool Culture
• Imaging Tests
• Serological Tests
• Colonoscopy
• ELISA
• Radioimmunoassay
• Tube Agglutination
• CT Scan
• Ultrasonography
• Colonoscopy
• Others

Global Yersinia Diagnostics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Immunoassay
• DNA Probes
• Polymerase Chain Reaction (PCR)
• Flow Cytometry
• Chromatography
• Others

Global Yersinia Diagnostics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Public Health Laboratories
• Commercial Laboratories
• Others

Global Yersinia Diagnostics Market Size & CAGR (2026-2033)

• North America (Product, Diagnostic Test, Technology, End User)
  • US
  • Canada
• Europe (Product, Diagnostic Test, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Diagnostic Test, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Diagnostic Test, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Diagnostic Test, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioAffinity Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gen-Probe Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations